BioNTech
BNTX
BNTX
250 hedge funds and large institutions have $4.04B invested in BioNTech in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 84 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less call options, than puts
Call options by funds: $200M | Put options by funds: $291M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
53% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 55
Holders
250
Holding in Top 10
4
Calls
$200M
Puts
$291M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$19.6M | |
| 3 | +$17.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.6M |
| 5 |
Temasek Holdings
Singapore
|
+$15.1M |
Top Sellers
| 1 | -$103M | |
| 2 | -$62.7M | |
| 3 | -$62.5M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$50.3M |
| 5 |
Morgan Stanley
New York
|
-$41.9M |